Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 98

1.

Evaluation of a Mental Care System for Patients Recuperating in a Sterile Room after Hematopoietic Cell Transplantation.

Joko S, Ohsuga M, Tada Y, Ishikawa J.

Conf Proc IEEE Eng Med Biol Soc. 2019 Jul;2019:1314-1317. doi: 10.1109/EMBC.2019.8857157.

PMID:
31946134
2.

Rare and unusual spindle cell tumour.

Nakamura H, Kitamura M, Murata H, Kida S, Ishikawa J, Kamiura S, Nakatsuka SI.

J Clin Pathol. 2019 Dec 4. pii: jclinpath-2019-206144. doi: 10.1136/jclinpath-2019-206144. [Epub ahead of print] No abstract available.

PMID:
31801801
3.

GVHD prophylaxis by tacrolimus and mini-MTX in single-unit CBT: a single institute experience.

Fuji S, Tada Y, Nakata R, Nakata K, Koike M, Kida S, Tsutsumi K, Masaie H, Yoshida H, Ishikawa J.

Int J Hematol. 2020 Feb;111(2):278-283. doi: 10.1007/s12185-019-02762-3. Epub 2019 Oct 28.

PMID:
31659626
4.

Cessation of nilotinib in patients with chronic myelogenous leukemia who have maintained deep molecular responses for 2 years: a multicenter phase 2 trial, stop nilotinib (NILSt).

Nagafuji K, Matsumura I, Shimose T, Kawaguchi T, Kuroda J, Nakamae H, Miyamoto T, Kadowaki N, Ishikawa J, Imamura Y, Yamazaki H, Akashi K, Kanakura Y.

Int J Hematol. 2019 Dec;110(6):675-682. doi: 10.1007/s12185-019-02736-5. Epub 2019 Sep 19.

PMID:
31538327
5.

The genome sequence of Streptomyces rochei 7434AN4, which carries a linear chromosome and three characteristic linear plasmids.

Nindita Y, Cao Z, Fauzi AA, Teshima A, Misaki Y, Muslimin R, Yang Y, Shiwa Y, Yoshikawa H, Tagami M, Lezhava A, Ishikawa J, Kuroda M, Sekizuka T, Inada K, Kinashi H, Arakawa K.

Sci Rep. 2019 Jul 29;9(1):10973. doi: 10.1038/s41598-019-47406-y.

6.

The effect of melphalan dose and total body irradiation as reduced-intensity conditioning for acute lymphoblastic leukemia patients undergoing allogeneic stem cell transplantation.

Harada K, Tachibana T, Ohashi K, Ozawa Y, Sawa M, Kondo T, Ishikawa J, Onizuka M, Imada K, Fujisaki T, Tanaka J, Fukuda T, Atsuta Y, Kako S.

Leuk Lymphoma. 2019 Dec;60(14):3521-3528. doi: 10.1080/10428194.2019.1636986. Epub 2019 Jul 10.

PMID:
31290354
7.

Photocatalytic CO2 Reduction Using Various Heteroleptic Diimine-Diphosphine Cu(I) Complexes as Photosensitizers.

Yamazaki Y, Onoda T, Ishikawa J, Furukawa S, Tanaka C, Utsugi T, Tsubomura T.

Front Chem. 2019 Apr 30;7:288. doi: 10.3389/fchem.2019.00288. eCollection 2019.

8.

Comparison of Outcomes of Allogeneic Transplantation for Primary Myelofibrosis among Hematopoietic Stem Cell Source Groups.

Murata M, Takenaka K, Uchida N, Ozawa Y, Ohashi K, Kim SW, Ikegame K, Kanda Y, Kobayashi H, Ishikawa J, Ago H, Hirokawa M, Fukuda T, Atsuta Y, Kondo T.

Biol Blood Marrow Transplant. 2019 Aug;25(8):1536-1543. doi: 10.1016/j.bbmt.2019.02.019. Epub 2019 Mar 1.

PMID:
30826464
9.

Effects of HLA mismatch on cytomegalovirus reactivation in cord blood transplantation.

Yokoyama H, Kanda J, Kato S, Kondo E, Maeda Y, Saji H, Takahashi S, Onizuka M, Onishi Y, Ozawa Y, Kanamori H, Ishikawa J, Ohno Y, Ichinohe T, Takanashi M, Kato K, Atsuta Y, Kanda Y; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Bone Marrow Transplant. 2019 Jul;54(7):1004-1012. doi: 10.1038/s41409-018-0369-0. Epub 2018 Nov 6.

PMID:
30401965
10.

Insight into the draft whole-genome sequence of the dermatophyte Arthroderma vanbreuseghemii.

Alshahni MM, Yamada T, Yo A, Murayama SY, Kuroda M, Hoshino Y, Ishikawa J, Watanabe S, Makimura K.

Sci Rep. 2018 Oct 11;8(1):15127. doi: 10.1038/s41598-018-33505-9.

11.

Pure intravascular recurrence of CD5-positive diffuse large B-cell lymphoma primarily arising from the nasal cavities.

Kano R, Masaie H, Hino A, Yasuoka H, Nagata S, Ishikawa J, Nakatsuka SI.

Diagn Pathol. 2018 Jul 24;13(1):46. doi: 10.1186/s13000-018-0724-x.

12.

Five-day regimen of azacitidine for lower-risk myelodysplastic syndromes (refractory anemia or refractory anemia with ringed sideroblasts): A prospective single-arm phase 2 trial.

Morita Y, Maeda Y, Yamaguchi T, Urase F, Kawata S, Hanamoto H, Tsubaki K, Ishikawa J, Shibayama H, Matsumura I, Matsuda M.

Cancer Sci. 2018 Oct;109(10):3209-3215. doi: 10.1111/cas.13739. Epub 2018 Aug 26.

13.

Pomalidomide with or without dexamethasone for relapsed/refractory multiple myeloma in Japan: a retrospective analysis by the Kansai Myeloma Forum.

Matsumura-Kimoto Y, Kuroda J, Kaneko H, Kamitsuji Y, Fuchida SI, Nakaya A, Shibayama H, Uoshima N, Yokota I, Uchiyama H, Yagi H, Kosugi S, Matsui T, Ishikawa J, Matsuda M, Ohta K, Iida M, Tanaka H, Kobayashi M, Wada K, Shimazaki C, Nomura S, Imada K, Hino M, Matsumura I, Kanakura Y, Takaori-Kondo A; Kansai Myeloma Forum Investigators.

Int J Hematol. 2018 May;107(5):541-550. doi: 10.1007/s12185-018-2416-4. Epub 2018 Jan 29.

PMID:
29380179
14.

Efficacy and safety of switching to nilotinib in patients with CML-CP in major molecular response to imatinib: results of a multicenter phase II trial (NILSw trial).

Ishikawa J, Matsumura I, Kawaguchi T, Kuroda J, Nakamae H, Miyamoto T, Matsuoka KI, Shibayama H, Hino M, Hirase C, Kamimura T, Shimose T, Akashi K, Kanakura Y.

Int J Hematol. 2018 May;107(5):535-540. doi: 10.1007/s12185-018-2401-y. Epub 2018 Jan 23.

PMID:
29362980
15.

Intracranial stenting for nilotinib treatment-associated cerebrovascular stenosis in chronic myeloid leukemia.

Ozaki T, Nakamura H, Izutsu N, Masaie H, Ishikawa J, Kinoshita M.

Interv Neuroradiol. 2017 Oct;23(5):527-530. doi: 10.1177/1591019917710810. Epub 2017 Jun 5.

16.

Heterologous production of kasugamycin, an aminoglycoside antibiotic from Streptomyces kasugaensis, in Streptomyces lividans and Rhodococcus erythropolis L-88 by constitutive expression of the biosynthetic gene cluster.

Kasuga K, Sasaki A, Matsuo T, Yamamoto C, Minato Y, Kuwahara N, Fujii C, Kobayashi M, Agematu H, Tamura T, Komatsu M, Ishikawa J, Ikeda H, Kojima I.

Appl Microbiol Biotechnol. 2017 May;101(10):4259-4268. doi: 10.1007/s00253-017-8189-5. Epub 2017 Feb 27.

PMID:
28243709
17.

Sequential Onset of Varicella-Zoster Virus Encephalomeningitis and Progressive Multifocal Leukoencephalopathy in an Allogeneic Hematopoietic Stem Cell Transplant Recipient.

Yamashita Y, Kusakabe S, Toda J, Ohshima K, Masaie H, Yagi T, Yoshida H, Ishikawa J.

Exp Clin Transplant. 2018 Oct;16(5):628-630. doi: 10.6002/ect.2016.0077. Epub 2016 Dec 12.

18.

Changes from imatinib mesylate to second generation tyrosine kinase inhibitors improve renal impairment with imatinib mesylate in chronic myelogenous leukemia.

Hino A, Yoshida H, Tada Y, Koike M, Minami R, Masaie H, Ishikawa J.

Int J Hematol. 2016 Nov;104(5):605-611. Epub 2016 Jul 26.

PMID:
27460678
19.

Haploidentical and Matched Sibling Donor Hematopoietic Cell Transplantation for Patients with HLA-Homozygous Haplotypes.

Kanda J, Ikegame K, Fuji S, Kurokawa M, Kanamori H, Fukuda T, Ohashi K, Ishikawa J, Ogawa H, Inoue M, Ichinohe T, Atsuta Y, Kanda Y; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant. 2016 Nov;22(11):2031-2037. doi: 10.1016/j.bbmt.2016.07.020. Epub 2016 Aug 1.

20.

Prevalence of and Factors Associated With Sleep-Related Eating Disorder in Psychiatric Outpatients Taking Hypnotics.

Takaesu Y, Ishikawa J, Komada Y, Murakoshi A, Futenma K, Nishida S, Inoue Y.

J Clin Psychiatry. 2016 Jul;77(7):e892-8. doi: 10.4088/JCP.15m10055.

PMID:
27464322

Supplemental Content

Loading ...
Support Center